Press Releases April 30, 2026 04:01 PM

Atlanticus to Host First Quarter 2026 Earnings Call and Webcast on May 7, 2026 at 5:00 p.m. ET

Atlanticus to release Q1 2026 financial results and host earnings call on May 7, 2026

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
ATLC

Atlanticus Holdings Corporation announced it will host a conference call and live webcast on May 7, 2026, to discuss its first quarter 2026 financial results and operating performance. The webcast and related earnings materials will be available on the company's Investor Relations website.

Atlanticus to Host First Quarter 2026 Earnings Call and Webcast on May 7, 2026 at 5:00 p.m. ET
ATLC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Atlanticus enables partners in banking, retail, healthcare, and automotive sectors to offer inclusive financial solutions leveraging proprietary technology.
  • The company has over 30 years of experience, servicing more than 20 million customers and over $50 billion in consumer loans.
  • The Q1 2026 earnings call will provide updated financial and operational insights to investors and stakeholders.

ATLANTA, April 30, 2026 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” the “Company,” “we,” “our” or “us”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced that it will host a conference call and live webcast to discuss its first quarter financial results and operating performance on Thursday, May 7, 2026 at 5:00 p.m. Eastern Time.

The live webcast will be accessible at the Atlanticus Investor Relations website at https://investors.atlanticus.com/news-market-information/event-calendar, along with the Company’s first quarter earnings press release and first quarter investor presentation. An archived version of the webcast will be available on the Atlanticus Holdings Corporation Investor Relations website for 45 days.

About Atlanticus Holdings Corporation

Atlanticus Holdings Corporation empowers better financial outcomes for everyday Americans by enabling bank, retail, healthcare, and automotive partners to offer more inclusive financial solutions to consumers. Leveraging proprietary technology and advanced analytics, Atlanticus applies more than 30 years of operating experience, servicing over 20 million customers and more than $50 billion in consumer loans, to support lenders across a broad range of consumer credit products. For more information, visit www.atlanticus.com.

Contact:
Investor Relations, investors@atlanticus.com
Dan Mauch, dan.mauch@atlanticus.com
Sara Savarino, sara.savarino@atlanticus.com


Risks

  • Potential uncertainties in financial performance or operating metrics not yet revealed prior to the earnings call.
  • Economic or credit environment changes that could impact consumer lending and the company's loan portfolio.
  • Market and investor reactions depend on the details disclosed during the earnings release and conference call.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026